Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mirae Asset Financial Group is a leading global financial services conglomerate headquartered in Seoul, South Korea, with a significant presence in the life sciences and biotechnology sectors through its investment arms. The group operates through various subsidiaries, including Mirae Asset Global Investments, Mirae Asset Securities, and Mirae Asset Capital, which manage specialized healthcare and biotech funds. It is recognized as one of the most active institutional investors in the global biotech ecosystem, providing venture capital, private equity, and IPO underwriting services to emerging biopharma companies. Mirae Asset has been a key backer of numerous high-profile biotech firms across Asia, Europe, and the United States, focusing on innovative therapeutic modalities and medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirae Asset Group.